Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akan

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|April 4, 2000
A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignanciesT Demirer, O Ilhan, N M Mandel, et al.
Bone Marrow Transplantation|May 16, 2003
Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centersM Beksac, H Celebi, D Sargín, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
The Incidence of Hepatitis G Virus in Patients with Hematological Malignancies: The Relationship to the Number of Blood and Blood Products TransfusionsR İdilman, C Üstün, Ö Aslan, et al.
Bone Marrow Transplantation|June 29, 2000
Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina HospitalO Arslan, H Coşkun, M Arat, et al.
Journal of Clinical Apheresis|December 18, 2001
CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantationT Demirer, O Ilhan, M Arat, et al.
Bone Marrow Transplantation|April 21, 2001
Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantationM Ozcan, C Ustün, E Akçağlayan, et al.
Journal of Hepatology|August 24, 1999
Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safeC Ustün, R Idilman, G Gürman, et al.
Bone Marrow Transplantation|January 12, 2010
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer studyR Herbrecht, J Maertens, L Baila, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2009
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patientsC Viscoli, R Herbrecht, H Akan, et al.
Journal of Viral Hepatitis|March 5, 2004
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignanciesR Idilman, M Arat, E Soydan, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|April 4, 2000
A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignanciesT Demirer, O Ilhan, N M Mandel, et al.
Bone Marrow Transplantation|May 16, 2003
Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centersM Beksac, H Celebi, D Sargín, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
The Incidence of Hepatitis G Virus in Patients with Hematological Malignancies: The Relationship to the Number of Blood and Blood Products TransfusionsR İdilman, C Üstün, Ö Aslan, et al.
Bone Marrow Transplantation|June 29, 2000
Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina HospitalO Arslan, H Coşkun, M Arat, et al.
Journal of Clinical Apheresis|December 18, 2001
CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantationT Demirer, O Ilhan, M Arat, et al.
Bone Marrow Transplantation|April 21, 2001
Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantationM Ozcan, C Ustün, E Akçağlayan, et al.
Journal of Hepatology|August 24, 1999
Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safeC Ustün, R Idilman, G Gürman, et al.
Bone Marrow Transplantation|January 12, 2010
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer studyR Herbrecht, J Maertens, L Baila, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2009
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patientsC Viscoli, R Herbrecht, H Akan, et al.
Journal of Viral Hepatitis|March 5, 2004
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignanciesR Idilman, M Arat, E Soydan, et al.
Pageof 11